Skip to main content

ILLUMINA INC

For the period ended Dec 29, 2024. Filed Feb 12, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 12, 2025

ILMN$220.78+3.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

12. Segment and Geographic Information

Reportable Segment Information

As of December 29, 2024, we haveone reportable segment, Core Illumina. Prior to the Spin-Off of GRAIL, on June 24, 2024, our reportable segments included both Core Illumina and GRAIL. See note 2. GRAIL Spin-Off for details. We continue to disclose certain historical information for GRAIL prior to the Spin-Off. Segment information is consistent with how our Chief Operating Decision Maker (CODM), who is our Chief Executive Officer, reviews financial information, makes operating decisions, allocates resources, and assesses performance. We also consider the way budgets and forecasts are prepared and reviewed and the basis on which executive compensation is determined.

Core Illumina: Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina sells products and provides services to GRAIL, and vice versa, in accordance with contractual agreements between the entities.

GRAIL: GRAIL is a healthcare company focused on early detection of multiple cancers. Prior to the Spin-Off of GRAIL into a separate, independent public company, GRAIL was required to be held and operated separately and independently from Illumina pursuant to the transitional measures ordered by the European Commission.

Our CODM allocates resources and evaluates business performance based on revenues and net income (loss). Net income (loss) is used in the annual budgeting and monthly forecasting processes and to monitor and assess budgeted/forecasted versus actual results. Our CODM does not evaluate segments using asset information. The accounting policies for segments are the same as those described in the summary of significant accounting policies.

The following tables present selected financial information with respect to segments for the periods presented:

In millions202420232022
Core Illumina:
Revenue(1)$4,332$4,438$4,553
Less:
Cost of revenue1,4241,5821,446
Research and development9881,0301,004
Selling and marketing638648677
General and administrative262600326
Goodwill and intangible impairment36—
Legal contingency and settlement(456)20619
Core Illumina income from operations1,473552481
GRAIL:
Revenue559355
Total operating expenses(2)2,3601,7144,712
Consolidated other expense, net34648157
Consolidated provision for income taxes444468
Intersegment eliminations(1)—(3)
Consolidated net loss$(1,223)$(1,161)$(4,404)

(1)Core Illumina revenue for 2024, 2023, and 2022 included intercompany revenue of $15 million, $26 million, and $24 million, respectively.

(2)GRAIL operating expenses are inclusive of cost of revenue, research and development, selling and marketing, general and administrative, and goodwill and intangible impairment for the comparative periods prior to the Spin-Off on June 24, 2024.

In millions202420232022
Depreciation and amortization:
Core Illumina$280$273$240
GRAIL74159154
Consolidated depreciation and amortization$354$432$394
Capital expenditures:
Core Illumina$137$183$262
GRAIL51324
Eliminations—(1)—
Consolidated capital expenditures$142$195$286

Geographic Data

Long-lived assets, consisting of property and equipment and operating lease right-of-use assets, were as follows:

In millionsDecember 29,2024December 31,2023
United States$750$1,040
Singapore279298
United Kingdom124136
Other countries8177
Total long-lived assets, net$1,234$1,551

Refer to note 3. Revenue for revenue by geographic area.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.